Evidence map›Paper›PMID 23511474›Full record

ArticleNature communications2013

β-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity.

A Gutierrez, L Laureti, S Crussard, H Abida, A Rodríguez-Rojas, J Blázquez, Z Baharoglu, D Mazel, F Darfeuille, J Vogel and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 387 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Regulation of drug resistance and virulence ofFrontiers in microbiology · 2026
    Article
  6. Article
  7. Regulation of the Expression ofAntibiotics (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Comprehensive Genomic Analysis ofMicroorganisms · 2025
    Article
  18. Article
  19. Review
  20. Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

A GutierrezINSERM U1001, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine Paris Descartes, Paris, France.
L Laureti
S Crussard
H Abida
A Rodríguez-Rojas
J Blázquez
Z Baharoglu
D Mazel
F Darfeuille
J Vogel
I Matic
Inserm · FRCentro Nacional de Biotecnología · ESInstitut Pasteur · FRSorbonne Paris Cité · FRUniversité Paris Cité · FRUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regardless of their targets and modes of action, subinhibitory concentrations of antibiotics can have an impact on cell physiology and trigger a large variety of cellular responses in different bacterial species. Subinhibitory concentrations of β-lactam antibiotics cause reactive oxygen species production and induce PolIV-dependent mutagenesis in Escherichia coli. Here we show that subinhibitory concentrations of β-lactam antibiotics induce the RpoS regulon. RpoS-regulon induction is required for PolIV-dependent mutagenesis because it diminishes the control of DNA-replication fidelity by depleting MutS in E. coli, Vibrio cholerae and Pseudomonas aeruginosa. We also show that in E. coli, the reduction in mismatch-repair activity is mediated by SdsR, the RpoS-controlled small RNA. In summary, we show that mutagenesis induced by subinhibitory concentrations of antibiotics is a genetically controlled process. Because this mutagenesis can generate mutations conferring antibiotic resistance, it should be taken into consideration for the development of more efficient antimicrobial therapeutic strategies.

Indexed as

MutagenesisAnti-Bacterial AgentsBacteriaBacterial Proteinsbeta-LactamsDNA ReplicationEscherichia coliPseudomonas aeruginosaReactive Oxygen SpeciesSigma FactorVibrio choleraeAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsReactive Oxygen SpeciesSigma Factorsigma factor KatF protein, Bacteria

Identifiers

PMID23511474
PMCPMC3615471
OpenAlexW2006259275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.